Balyasny Asset Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.75M | Sell |
27,600
-343,200
| -93% | -$79.9M | 0.01% | 1228 |
|
|
2025
Q4 | $76.7M | Sell |
370,800
-68,100
| -16% | -$13.5M | 0.1% | 228 |
|
|
2025
Q3 | $81.4M | Buy |
438,900
+359,800
| +455% | +$61.6M | 0.1% | 218 |
|
|
2025
Q2 | $12.1M | Sell |
79,100
-122,900
| -61% | -$18.9M | 0.02% | 887 |
|
|
2025
Q1 | $33.5M | Buy |
202,000
+162,700
| +414% | +$25.5M | 0.06% | 415 |
|
|
2024
Q4 | $5.68M | Sell |
39,300
-137,600
| -78% | -$21.3M | 0.01% | 1212 |
|
|
2024
Q3 | $28.7M | Buy |
176,900
+123,500
| +231% | +$19.7M | 0.05% | 501 |
|
|
2024
Q2 | $7.8M | Buy |
53,400
+42,600
| +394% | +$6.34M | 0.01% | 985 |
|
|
2024
Q1 | $1.71M | Sell |
10,800
-34,200
| -76% | -$5.44M | ﹤0.01% | 1588 |
|
|
2023
Q4 | $7.05M | Buy |
45,000
+10,200
| +29% | +$1.56M | 0.01% | 1002 |
|
|
2023
Q3 | $5.42M | Buy |
+34,800
| New | +$5.74M | 0.01% | 1073 |
|
|
2023
Q2 | – | Sell |
-135,300
| Closed | -$21M | – | 2528 |
|
|
2023
Q1 | $21M | Sell |
135,300
-218,400
| -62% | -$35.3M | 0.05% | 497 |
|
|
2022
Q4 | $62.5M | Buy |
353,700
+120,300
| +52% | +$20.8M | 0.17% | 151 |
|
|
2022
Q3 | $38.1M | Buy |
233,400
+122,500
| +110% | +$20.7M | 0.12% | 212 |
|
|
2022
Q2 | $19.7M | Buy |
110,900
+32,200
| +41% | +$5.74M | 0.06% | 427 |
|
|
2022
Q1 | $13.9M | Buy |
+78,700
| New | +$13.4M | 0.04% | 566 |
|
|
2021
Q3 | – | Sell |
-9,700
| Closed | -$1.6M | – | 2180 |
|
|
2021
Q2 | $1.6M | Buy |
+9,700
| New | +$1.61M | 0.01% | 1086 |
|
|
2020
Q2 | – | Sell |
-40,000
| Closed | -$5.25M | – | 1315 |
|
|
2020
Q1 | $5.25M | Buy |
+40,000
| New | +$5.67M | 0.06% | 391 |
|
|
2019
Q2 | – | Sell |
-200,000
| Closed | -$28M | – | 1604 |
|
|
2019
Q1 | $28M | Sell |
200,000
-599,000
| -75% | -$80.2M | 0.19% | 161 |
|
|
2018
Q4 | $103M | Buy |
799,000
+704,000
| +741% | +$98.2M | 0.74% | 14 |
|
|
2018
Q3 | $13.3M | Buy |
+95,000
| New | +$12.6M | 0.06% | 400 |
|
|
2017
Q3 | – | Sell |
-300,000
| Closed | -$39.7M | – | 1984 |
|
|
2017
Q2 | $39.7M | Buy |
+300,000
| New | +$38.3M | 0.16% | 165 |
|
|
2017
Q1 | – | Sell |
-162,700
| Closed | -$18.7M | – | 1683 |
|
|
2016
Q4 | $18.7M | Sell |
162,700
-829,254
| -84% | -$95.8M | 0.1% | 288 |
|
|
2016
Q3 | $84M | Buy |
+991,954
| New | +$120M | 0.49% | 43 |
|
Other funds holding JNJ
VCM
VPM
Balyasny Asset Management's JNJ Position: Q1 2026 in Review
Balyasny Asset Management increased its Johnson & Johnson (JNJ) stake by 1,410% in Q1 2026, buying an estimated $131M and bringing the position to 600,849 shares worth $147M. The position accounts for 0.19% of the portfolio, ranked #101.
Balyasny Asset Management first reported a position in JNJ in Q3 2013 and has held it in 39 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Balyasny Asset Management held 600,849 shares of Johnson & Johnson worth $147M as of Q1 2026.
- Balyasny Asset Management bought 561,069 Johnson & Johnson shares in Q1 2026, an estimated $131M.
- Johnson & Johnson made up 0.19% of Balyasny Asset Management's portfolio in Q1 2026, its #101 holding.
- Balyasny Asset Management first reported a position in Johnson & Johnson in Q3 2013 and has held it in 39 quarters since.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.